FDA Inspection 736419 — Osiris Therapeutics Inc
The FDA completed an inspection of Osiris Therapeutics Inc on July 14, 2011 in Columbia, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Columbia, MD (United States)